Table 4.

In vitro cytotoxic activity of the investigated peptides against LLC-MK2 cells.

Peptide	Cell Viability (%)
	25 µM	50 µM	100 µM
K13L	105.95 ± 1.47	105.04 ± 0.20	101.26 ± 0.38
G17K	99.07 ± 1.57	99.73 ± 0.45	99.07 ± 1.57
S17K	103.47 ± 2.00	102.69 ± 1.37	101.73 ± 1.82
D15R	101.32 ± 1.92	101.25 ± 0.19	103.00 ± 1.49
D15T	108.50 ± 0.92	107.55 ± 1.48	108.50 ± 5.15